Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridostigmine in Heart Failure
NCT01415921Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Oct 2011
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pyridostigmine in heart failure (HF), sponsored by NYU Langone Health. Started Oct 2011; status: completed.
02
Drugs
pyridostigmine
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01415921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01415921.